Provention Bio (PRVB) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free PRVB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMacrogenics Inc MGNXmorningstar.com - December 29 at 11:00 PMCambridge Investment Research Advisors Inc. Increases Stock Holdings in Provention Bio, Inc. (NASDAQ:PRVB)marketbeat.com - May 29 at 4:36 AMProvention Bio, Inc. (NASDAQ:PRVB) Stock Holdings Increased by Swiss National Bankmarketbeat.com - May 26 at 4:41 AMArizona State Retirement System Purchases 7,068 Shares of Provention Bio, Inc. (NASDAQ:PRVB)marketbeat.com - May 25 at 4:29 AMSG Americas Securities LLC Purchases New Position in Provention Bio, Inc. (NASDAQ:PRVB)marketbeat.com - May 17 at 4:13 AMZurcher Kantonalbank Zurich Cantonalbank Boosts Stock Holdings in Provention Bio, Inc. (NASDAQ:PRVB)marketbeat.com - May 8 at 4:39 AMProvention Bio, Inc. (NASDAQ:PRVB) Given Consensus Rating of "Hold" by Brokeragesmarketbeat.com - May 7 at 1:20 AMProvention Bio, Inc. (NASDAQ:PRVB) Shares Purchased by New York State Common Retirement Fundmarketbeat.com - May 3 at 4:14 AMSanofi/Provention: innovative diabetes drug is a good fitfinance.yahoo.com - May 1 at 10:47 AMThose who invested in Provention Bio (NASDAQ:PRVB) a year ago are up 456%finance.yahoo.com - April 29 at 9:55 AMSanofi completes Provention Bio acquisitionseekingalpha.com - April 28 at 9:22 AMEarnings Preview: Provention Bio, Inc. (PRVB) Q1 Earnings Expected to Declinefinance.yahoo.com - April 27 at 1:01 PMmarketbeat.com - April 27 at 6:08 AMSanofi - Aventis Groupe: Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.finanznachrichten.de - April 27 at 2:00 AMProvention Bio gains after HSR waiting period for Sanofi deal expiredseekingalpha.com - April 26 at 3:59 PMPress Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.benzinga.com - April 26 at 10:51 AMPRVB Apr 2023 23.000 putfinance.yahoo.com - April 22 at 10:13 AMProvention Bio, Inc. (NASDAQ:PRVB) Receives Average Recommendation of "Hold" from Analystsmarketbeat.com - April 12 at 2:15 AMSanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Informationmsn.com - April 11 at 3:59 PMRice Hall James & Associates LLC Has $1.92 Million Holdings in Provention Bio, Inc. (NASDAQ:PRVB)marketbeat.com - April 9 at 6:35 AMOppenheimer Equities Analysts Cut Earnings Estimates for Provention Bio, Inc. (NASDAQ:PRVB)marketbeat.com - April 3 at 1:56 AMProvention Bio, Inc. (NASDAQ:PRVB) Just Reported And Analysts Have Been Cutting Their Estimatesfinance.yahoo.com - April 2 at 10:41 AMGaithersburg’s Novavax locks in consulting deal with outgoing R&D headbizjournals.com - March 27 at 7:11 PMProvention Bio, Inc. (NASDAQ:PRVB) Given Average Recommendation of "Hold" by Analystsmarketbeat.com - March 18 at 1:16 AM(PRVB): Johnson Fistel Investigates Proposed Sale of Provention Bio Inc.; Is $25.00 a Fair Price?benzinga.com - March 17 at 7:02 PMQ4 2022 MacroGenics Inc Earnings Callfinance.yahoo.com - March 16 at 9:12 AMProvention Bio's Earnings Outlookbenzinga.com - March 15 at 2:10 PMProvention Bio (NASDAQ:PRVB) Earns "Neutral" Rating from Sumitomo Mitsui Financial Groupmarketbeat.com - March 15 at 8:16 AMSMBC Nikko Downgrades Provention Bio (PRVB)msn.com - March 14 at 10:52 PMJefferies Downgrades Provention Bio (PRVB)msn.com - March 14 at 10:52 PMProvention Bio shares soar after Sanofi agrees to buy company in $2.9B cash dealproactiveinvestors.com - March 14 at 5:52 PMShort Volatility Alert: Provention Bio Incbenzinga.com - March 14 at 5:52 PM4 Analysts Have This to Say About Provention Biomarkets.businessinsider.com - March 14 at 9:15 AMShareholder Alert: Ademi LLP investigates whether Provention Bio, Inc. has obtained a Fair Price in its transaction with Sanofibenzinga.com - March 13 at 6:14 PMProvention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Callfinance.yahoo.com - March 13 at 6:14 PMSanofi agrees to $2.9B purchase of Provention Bio in bid to boost diabetes drugmsn.com - March 13 at 6:14 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Provention Bio, Inc. Buyoutbenzinga.com - March 13 at 6:14 PMPRVB STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Provention Bio, Inc. Is Fair to Shareholdersbusinesswire.com - March 13 at 9:33 AMWhy Is Provention Bio (PRVB) Stock Up 263% Today?investorplace.com - March 13 at 9:07 AMProvention Bio Stock Soars on $2.9 Billion Acquisition by Sanofibarrons.com - March 13 at 8:56 AMSanofi to Acquire Provention Bio for Around $2.9 Blnwsj.com - March 13 at 3:55 AMFrance's Sanofi to acquire US-based Provention Bio for $2.9 blnreuters.com - March 13 at 3:55 AMSanofi To Buy Provention Bio For Around $2.9 Bln In Cashmarkets.businessinsider.com - March 13 at 3:55 AMUPDATE 1-France's Sanofi to acquire US-based Provention Bio for $2.9 blnfinance.yahoo.com - March 13 at 3:55 AMSanofi to buy Provention Bio in deal worth $2.9 billionfinance.yahoo.com - March 13 at 3:55 AMWill Provention Bio, Inc. (PRVB) Report Negative Earnings Next Week? What You Should Knowfinance.yahoo.com - March 9 at 4:41 PMProvention Bio (PRVB) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - March 9 at 1:12 AM390,800 Shares in Provention Bio, Inc. (NASDAQ:PRVB) Purchased by Palo Alto Investors LPmarketbeat.com - March 6 at 12:45 PMProvention Bio: Good Prospects In Type 1 Diabetes, But Patent Protection Is A Worryseekingalpha.com - February 24 at 7:18 AMProvention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023finance.yahoo.com - February 23 at 9:46 AM Get Provention Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. PRVB Media Mentions By Week PRVB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRVB News Sentiment▼1.560.32▲Average Medical News Sentiment PRVB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRVB Articles This Week▼00▲PRVB Articles Average Week Get Provention Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Merus News Today Vera Therapeutics News Today Rhythm Pharmaceuticals News Today Corcept Therapeutics News Today Arvinas News Today Summit Therapeutics News Today Evotec News Today Rocket Pharmaceuticals News Today TG Therapeutics News Today Janux Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRVB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsBiden out June 13; Kamala won’t replace him?Paradigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provention Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
